The artificial pancreas (AP), known as closed-loop control of blood glucose in diabetes, is a
system combining a glucose sensor, a control algorithm, and an insulin infusion device. AP …

The control of diabetes is an interdisciplinary endeavor, which includes a significant
biomedical engineering component, with traditions of success beginning in the early 1960s …

An overview of glucose sensors is presented, with specific focus on the promise of non-
enzymatic electrochemical glucose sensors. The review addresses their merits and …

Background The value of continuous glucose monitoring in the management of type 1
diabetes mellitus has not been determined. Methods In a multicenter clinical trial, we …

Diabetes mellitus is a worldwide epidemic characterized by chronic hyperglycemia that
results from either a deficiency or tolerance in insulin. 1 In the United States, 8.3% of the …

Background Closed-loop systems link continuous glucose measurements to insulin delivery.
We aimed to establish whether closed-loop insulin delivery could control overnight blood …

Automated closed-loop insulin delivery, also referred to as the'artificial pancreas', has been
an important but elusive goal of diabetes treatment for many decades. Research milestones …

The use of different approaches for design and results presentation of studies for the clinical
performance evaluation of continuous glucose monitoring (CGM) systems has long been …

The artificial pancreas is a long-awaited goal for the management of type 1 diabetes, and its
development was recently triggered by the development of continuous glucose sensors …

High-quality performance of medical devices for glucose monitoring is important for a safe
and efficient usage of this diagnostic option by patients with diabetes. The mean absolute …